News and Insights of 3D Printing and Manufacturing
PostProcess Technologies, Inc. has announced an expansion of its Channel Partner network in the United States and Europe through partnerships with TriMech, GoEngineer and Lino Integrated Printing Solutions. All three companies will add PostProcess Technologies’ data-driven AM finishing solutions to their customer offerings.
Welcome to this month’s AM Focus: Medical. For the entire month of February, we are going to zoom in on the many possibilities that additive manufacturing is offering today to medical companies. In this article, we’re giving you a dose of FabRx, a pharmaceutical biotech company that develops pharmaceutical 3D printers and 3D printed tablets. Upcoming articles in the AM Focus will span innovative startups to giant multinational corporations, all of which are using AM in exciting ways. At the end of the month all the best content will be featured in 3dpbm’s Medical AM Focus 2020 eBook.
The medical AM segment is multifaceted, consisting of 3D printed medical devices, anatomical models, prosthetics and more. Within the industry, bioprinting has carved out a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, to name but a few. While much of the excitement surrounding bioprinting is focused on the future—what it could do—we want to look at what is happening now in the field that is exciting.
3dpbm’s AM Focus Medical continues to zoom in on the many possibilities that additive manufacturing is offering today to medical companies. We are now taking a closer look at Zimmer Biomet additive manufacturing, which includes the global distribution (exclusive in the US) of unique PEKK 3D printed implants by Oxford Performance Materials. In the previous episodes, we looked at other giants such as Stryker, J&J and Lima Corporate as well as interesting SMEs and startups. Upcoming episodes will continue to include many different types of players in this segment, ranging from highly innovative startups and SMEs to giant multinational corporations. At the end of the month, all the best content will be featured in 3dpbm’s Medical AM Focus 2020 eBook.
After acquiring a minority stake in additive company Burloak Technologies in 2017, Canada-based Samuel, Son & Co., Limited has announced the full acquisition of the company. Burloak, now fully owned by the Canadian metal manufacturing leader, specializes in AM and provides support to partners in the aerospace, automotive and industrial markets in the adoption and use of 3D printing.
The medical AM segment is multifaceted, consisting of 3D printed medical devices, anatomical models, prosthetics and more. Within the industry, bioprinting has carved out a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, to name but a few. While much of the excitement surrounding bioprinting is focused on the future—what it could do—we want to look at what is happening now in the field that is exciting.
Welcome to this month’s AM Focus: Medical. For the entire month of February, we are going to zoom in on the many possibilities that additive manufacturing is offering today to medical companies. In this article, we investigate Lazarus 3D, a specialist in soft 3D printed medical models that can be cut and sutured just like real organs. Upcoming articles in the AM Focus will span innovative startups to giant multinational corporations, all of which are using AM in exciting ways. At the end of the month all the best content will be featured in 3dpbm’s Medical AM Focus 2020 eBook.
American aerospace manufacturer Pratt & Whitney and Singapore-based engineering company ST Engineering have announced the industrialization of a process for 3D printing aero-engine components for the maintenance, repair and overhaul (MRO) of commercial engines. The partners also unveiled the first application using the process, an aero-engine part that is expected to be fully integrated into the repair process by mid-2020 at Component Aerospace Singapore, Pratt & Whitney’s repair specialist in the region.
The medical AM segment is multifaceted, consisting of 3D printed medical devices, anatomical models, prosthetics and more. Within the industry, bioprinting has carved out a prominent position, gaining interest across the board for its huge potentials in drug development and screening, therapeutic treatments and regenerative medicine, to name but a few. While much of the excitement surrounding bioprinting is focused on the future, we want to look at what is happening now in the field that is exciting.
Germany-based finishing solutions company DyeMansion has announced a new partnership agreement with PLM Group, a reseller of 3D printing technologies in the Nordic-Baltic region. PLM Group will now offer DyeMansion’s full range of finishing products alongside 3D printing systems from HP and 3D Systems and 3D printing software solutions. The distribution partnership also marks Dyemansion’s first authorized reseller in the Nordics and Baltics.